Congenital disorder of glycosylation type Ia (CDG-Ia): phenotypic spectrum of the R141H/F119L genotype
Open Access
- 1 September 2001
- journal article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 85 (3), 236-239
- https://doi.org/10.1136/adc.85.3.236
Abstract
AIMS To delineate common and variable features and outcome of children with congenital disorder of glycosylation type Ia (CDG-Ia) caused by the frequent R141H/F119LPMM2 genotype. METHODS Clinical data on 25 patients (mean age 7.6 years, range 0–19) were analysed. RESULTS All patients had an early presentation with severe feeding problems and failure to thrive, hypotonia, hepatic dysfunction, inverted nipples, and abnormal subcutaneous fat pads. Eighteen patients were hospitalised in the neonatal period. Developmental delay was obvious before age 6 months. During the first seven months mean standard deviation score (SDS) for weight and length decreased 2.7 (SD = 2) and 2.4 (SD = 2), respectively. Mental retardation, ataxia, muscular atrophy, and febrile seizures were consistent features after infancy. Variable features included pericardial effusions, afebrile seizures, and stroke like episodes. Computed tomography/magnetic resonance imaging of the brain was normal in two patients examined before 4 months of age, but 18 children examined after 3 months of age had cerebellar atrophy, and 10 children also had supratentorial atrophy. Subsequent imaging showed progression of the cerebellar and supratentorial atrophy in eight and four of 10 children, respectively. Mean head circumference SDS declined from zero to −1.9 SD from age 3 months to 5 years. Motor ability ranged from none to walking with a rolator, and vocabulary ranged from none to comprehensible speech. The overall mortality ascribed to CDG-Ia was 18%. CONCLUSION Patients with the R141H/F119L genotype have an early uniform presentation including severe failure to thrive, but their functional outcome is variable. This genotype may well cause clinical manifestations in the severe end of the spectrum of CDG-Ia.Keywords
This publication has 20 references indexed in Scilit:
- A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 casesJournal of Medical Genetics, 2001
- Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia)Human Mutation, 2000
- Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia)European Journal of Human Genetics, 2000
- Genotypes and phenotypes of patients in the UK with carbohydrate‐deficient glycoprotein syndrome type 1Journal of Inherited Metabolic Disease, 2000
- Carbohydrate-deficient glycoprotein syndrome type 1A: expression and characterisation of wild type and mutant PMM2 in E. coliEuropean Journal of Human Genetics, 1999
- Developmental patterns and neuropsychological assessment in patients with carbohydrate-deficient glycoconjugate syndrome type IA (phosphomannomutase deficiency)Brain & Development, 1999
- Olivopontocerebellar atrophy of neonatal onset and disialotransferrin developmental deficiency syndrome.Archives of Disease in Childhood, 1991
- The carbohydrate-deficient glycoprotein syndrome. A new inherited multisystemic disease with severe nervous system involvement.1991
- [Measurement of head circumference at health examination of children. A multicentre study].1982
- [Heights and weights of Danish children].1982